Anal cancer
Clinical trials for Anal cancer explained in plain language.
Never miss a new study
Get alerted when new Anal cancer trials appear
Sign up with your email to follow new studies for Anal cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets HPV-Driven cancers in phase II trial
Disease control Not yet recruitingThis phase II trial tests a combination of two drugs—SYS6026 and Enlonstobart—in people with advanced solid tumors that have spread and are linked to HPV types 16 or 18. The study aims to see if the combination is safe and shows signs of shrinking tumors. Participants must be at …
Matched conditions: ANAL CANCER
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood test could spot hidden throat cancers before symptoms start
Diagnosis Not yet recruitingThis study aims to see if a simple blood test can find HPV-related oropharyngeal cancer early in men aged 50 and older who have no symptoms. Researchers will check blood for two markers of HPV and then follow up with those who test positive to find and treat any tumors. If succes…
Matched conditions: ANAL CANCER
Sponsor: UNICANCER • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
A group therapy approach may ease sexual distress after GI cancer
Symptom relief Not yet recruitingThis trial tests a virtual mind-body group program for female survivors of colorectal and anal cancer who experience sexual well-being challenges. Participants join weekly group sessions with other survivors to learn coping skills for physical changes, social factors, and thought…
Matched conditions: ANAL CANCER
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Vitamins e and CoQ10 tested as shield against radiation damage
Symptom relief Not yet recruitingThis study tests whether taking high doses of vitamin E and CoQ10 daily for 90 days can reduce chronic side effects from pelvic radiation in people treated for prostate, uterine, cervical, or anal cancer. Researchers will monitor safety, side effects, and quality of life in 200 a…
Matched conditions: ANAL CANCER
Phase 1/2 • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could Self-Swabs make anal cancer screening easier for people with HIV?
Knowledge-focused Not yet recruitingThis trial tests whether people living with HIV can collect their own anal swabs for anal cancer screening, compared with swabs taken by a clinician. About 700 participants in Australia will provide both types of swabs, which will be checked for high-risk HPV and precancerous cel…
Matched conditions: ANAL CANCER
Sponsor: Kirby Institute • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
HIV and cancer: study seeks to uncover hidden risk factors
Knowledge-focused Not yet recruitingThis study looks at how certain cancers develop in people with HIV and what factors might increase their risk. Researchers will analyze medical data from 1,000 HIV-positive adults to track which types of cancer occur most often and why. The goal is to improve early detection and …
Matched conditions: ANAL CANCER
Sponsor: Shenzhen Third People's Hospital • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
HPV-Positive pelvic cancer: study probes hidden toll on sex life
Knowledge-focused Not yet recruitingThis study follows 42 women with HPV-positive pelvic cancer (cervix, vagina, vulva, or anus) to understand how radiotherapy, with or without surgery, affects their sexual quality of life. Participants complete questionnaires about sexual function and emotional distress over time.…
Matched conditions: ANAL CANCER
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC